Statement from an HHS Spokesperson
"We have been, and continue to, negotiate with Pfizer for additional doses. At no time did OWS turn down an offer from Pfizer for any number of millions of doses having a firm delivery date and quantity, and it's a shame that someone is... (1/5)

...misinforming the American public. We signed a contract in July to buy 100 million doses from Pfizer, prior to their Phase 3 clinical trials starting. 100 million doses was the amount of doses for which Pfizer provided a delivery schedule. (2/5)

Even before the data from Pfizer’s Phase 3 trial became available, OWS has been asking Pfizer for a delivery schedule for doses in excess of the original 100 million so that we could finalize an updated agreement with Pfizer. (3/5)

Should at any time we feel we are being treated unfairly, we will use every lever at our disposal to address the situation. (4/5)

We remain confident that across our portfolio of multiple vaccines we will have enough doses for any American who wants a vaccine by the end of Q2 2021." (5/5)